Innovating Works

Intervet Schering-Plough Animal Health

Desconocido
VACDIVA: A safe DIVA vaccine for African Swine Fever control and eradication INTERVET INTERNATIONAL BV participó en un H2020: H2020-SFS-2018-2020 African Swine Fever (ASF) is one of the most important viral diseases affecting swine, with a serious socio-economic impact. It is present i...
2019-09-12 - 2024-12-31 | Financiado
HONOURs: Host switching pathogens infectious outbreaks and zoonosis a Marie Sklodowska Curie Training Netwo... INTERVET INTERNATIONAL BV participó en un H2020: H2020-MSCA-ITN-2016 The ongoing increase of the human population accompanied by growing numbers of livestock to feed this population, as well as human invasion...
2016-12-20 - 2021-03-31 | Financiado
VAC2VAC: Vaccine lot to Vaccine lot comparison by consistency testing. INTERVET INTERNATIONAL BV participó en un H2020: H2020-JTI-IMI2-2015-03-two-stage Lot release testing of established vaccines relies on using animal models. Many of these models were developed decades ago and reflect the l...
2016-04-14 - 2022-02-28 | Financiado
MycoSynVac: Engineering of Mycoplasma pneumoniae as a broad spectrum animal vaccine INTERVET INTERNATIONAL BV participó en un H2020: H2020-BIOTEC-2014-2015 Mycoplasmas are the smallest cell wall less, free-living microorganisms. The lack of a cell wall makes them resistant to many of the common...
2015-02-11 - 2020-03-31 | Financiado
CLOSTNET: A Clostridal Biology Network to Facilitate European wide Medical Countermeasures and Commercial Expl... INTERVET INTERNATIONAL BV participó en un FP7: There is an urgent need to better understand the basic biology of Clostridium as a prerequisite for both countering the diseases they cause...
Financiado
PARAMET: A systematic analysis of parasite metabolism from metabolism to intervention INTERVET INTERNATIONAL BV participó en un FP7: Parasites exact a devastating toll on health and economic productivity, infecting man and also domestic livestock. Drugs used to combat par...
Financiado
SAPRO: Sustainable Approaches to Reduce Oomycete Saprolegnia Infections in Aquaculture INTERVET INTERNATIONAL BV participó en un FP7: The oomycete family contains some of the world’s most destructive fish pathogens. In Europe alone, these microorganisms collectively account...
Financiado
PIROVAC: Improvement of current and development of new vaccines for theileriosis and babesios of small rumina... INTERVET INTERNATIONAL BV participó en un FP7: The proposal deals with the establishment of control measures for two major tick-borne diseases of small ruminants: theileriosis caused by T...
Financiado
ORBIVAC: Development of Vaccines for bTV EHDV and AHSV INTERVET INTERNATIONAL BV participó en un FP7: The major outstanding challenges of orbivirus vaccine research is to develop vaccines that can afford a broad protective immune response aga...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.